First Time Loading...

Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399

Watchlist Manager
Jiangsu Bioperfectus Technologies Co Ltd Logo
Jiangsu Bioperfectus Technologies Co Ltd
SSE:688399
Watchlist
Price: 73.66 CNY 7.61% Market Closed
Updated: Apr 29, 2024
Section:
 

Wall Street
Price Targets

Price Targets Summary
Jiangsu Bioperfectus Technologies Co Ltd

There are no price targets for Jiangsu Bioperfectus Technologies Co Ltd.
Lowest Forecast
Wall Street Target
Not Available
Average Forecast
Wall Street Target
Not Available
Highest Forecast
Wall Street Target
Not Available
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Jiangsu Bioperfectus Technologies Co Ltd Competitors:
Price Targets
T
TOG
Thai Optical Group PCL
45% Downside
7979
Shofu Inc
0% Downside
NEOG
Neogen Corp
39% Upside
7447
Nagaileben Co Ltd
13% Downside
T
TOG
Thai Optical Group PCL
45% Downside
7979
Shofu Inc
0% Downside
NEOG
Neogen Corp
39% Upside
7447
Nagaileben Co Ltd
13% Downside
H
3593
Hogy Medical Co Ltd
2% Downside
P
6491
Pegavision Corp
15% Downside
BLFS
BioLife Solutions Inc
30% Upside
7730
Mani Inc
38% Upside

Revenue
Forecast

Revenue Estimate
Jiangsu Bioperfectus Technologies Co Ltd

Revenue forecast
is not available for
Jiangsu Bioperfectus Technologies Co Ltd

Operating Income
Forecast

Operating Income Estimate
Jiangsu Bioperfectus Technologies Co Ltd

Operating Income forecast
is not available for
Jiangsu Bioperfectus Technologies Co Ltd

Net Income
Forecast

Net Income Estimate
Jiangsu Bioperfectus Technologies Co Ltd

Net Income forecast
is not available for
Jiangsu Bioperfectus Technologies Co Ltd

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Jiangsu Bioperfectus Technologies Co Ltd's stock price target?
Not Available

Jiangsu Bioperfectus Technologies Co Ltd doesn't have any price targets made by Wall Street professionals.

ALPHA SPREAD
Join more than 132,600+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.